GSK’s two-drug HIV treatment meets main goal in late stage studies
(Reuters) – GlaxoSmithKline’s two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the…
Hypertension costly to patients, society
(Reuters Health) – Each year, U.S. adults with high blood pressure incur almost $2,000 more in annual healthcare costs, according to a new study “The increased cost burden of hypertension…
Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ
(Reuters) – Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street Journal reported on Monday, a combination that would give Stryker…
Fed up with rising costs, big U.S. firms dig into healthcare
SAN JOSE, Calif. (Reuters) – At its Silicon Valley headquarters, network gear maker Cisco Systems Inc is going to unusual lengths to take control of the relentless increase in its…
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) – A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company…
Medical workers in Congo city finish vaccinating contacts of Ebola patients
KINSHASA (Reuters) – Medical workers in Democratic Republic of Congo have given all the immediate contacts of Ebola patients in the city of Mbandaka an experimental vaccine as they try…
Many women with early-stage breast cancer can skip chemotherapy: study
CHICAGO (Reuters) – Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S.…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries might become a barrier to…
Leading oncology group wary of Trump drug price proposals
CHICAGO (Reuters) – America’s leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs, warning that patients must not be barred from medicines that…
Allergan plans sales of women’s health, infectious disease units
NEW YORK (Reuters) – Drugmaker Allergan Plc (AGN.N) plans to sell off its women’s health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide…